Kidney Medicare Drugs Awareness and Education Initiative A KIDNEY COMMUNITY INITIATIVE TO HELP PROFESSIONALS AND PEOPLE WITH KIDNEY DISEASE UNDERSTAND MEDICARE PRESCRIPTION DRUG COVERAGE
May 20, 2015
Kidney Medicare Drugs Awareness and Education Initiative
A KIDNEY COMMUNITY INITIATIVE TO HELP PROFESSIONALS AND PEOPLE WITH KIDNEY DISEASE
UNDERSTAND MEDICARE PRESCRIPTION DRUG COVERAGE
Kidney Medicare Drugs Awareness and Education Initiative
OUR MISSION
The Kidney Medicare Drugs Awareness and Education Initiative is
a service of the kidney community, designed to provide timely, consistent,
reliable, and up-to-date information about Medicare and Medicare
Prescription Drug Coverage (Part D).
Kidney Medicare Drugs Awareness and Education Initiative
• Ensure accuracy and comprehensiveness
• Enhance credibility
• Avoid duplication
• Minimize confusion
OBJECTIVES
Kidney Medicare Drugs Awareness and Education Initiative
OUR CHALLENGE• Medicare Part D is complex to understand, much
less explain.• Most materials and services are not geared to
people with kidney disease and professionals that treat them.
• Many people think Medicare Part D is only for those with low income.
• Many don’t want to ask the government for help.
Kidney Medicare Drugs Awareness and Education Initiative
More Challenges
• Awareness is limited, understanding is poor, and intent to enroll is low.
• Most must take action by May 15, 2006 to get the most savings and avoid higher premiums.
• Acceptance and use of Medicare Part D to its fullest will require: – Ongoing consistent education;– Communication between patients and healthcare
providers.
Kidney Medicare Drugs Awareness and Education Initiative
OUR TARGET AUDIENCES
• Patients• Physicians and
office staff• Kidney care team• Dialysis providers• Transplant
facilities• Kidney
organizations
• Government (CMS, SSA)
• Federal contractors (Networks, SHIPs)
• Specialty pharmacies
• Media
Kidney Medicare Drugs Awareness and Education Initiative
BACKGROUND• Novartis community meeting in Spring 2005 showed how
confused kidney community was about Part D• Kidney Care Partners suggested NKF take lead to form
community-wide initiative• Reviewed and collected materials from:
– Federal and state agencies– Other kidney organizations– Other health organizations– Health and patient advocacy groups
• Held planning meetings with community representatives• Held workgroup meetings• Established communications with agency key personnel• Developed communications plan• Began developing kidney-specific resources
Kidney Medicare Drugs Awareness and Education Initiative
OUR KEY MESSAGES
• Medicare is about to undergo significant, historic change as it implements prescription drug coverage (Part D).
• Medicare Part D offers most on Medicare—including those with kidney disease—the opportunity to save significantly on drug costs.
• Some may not need Part D and others may risk other health coverage by joining a Part D plan (employer, COBRA, Medicare Advantage)
Kidney Medicare Drugs Awareness and Education Initiative
More Key Messages
• Most info is for the “average” person with Medicare, but www.kidneydrugcoverage.org has kidney-specific info about Medicare Part D.
• Those who have or choose “kidney-friendly” coverage will save more. Finding and choosing these plans may take some effort.
• Social workers can help by collecting and saving notices patients receive from government, current plans, Medicare drug plans
Kidney Medicare Drugs Awareness and Education Initiative
Kidney Specific Issues
• Patients must review plans for current and future drugs since health and/or treatment may change
• Part A drugs will stay Part A• Part B drugs (immunosuppressants, EPO,
Vitamin D, etc.) will stay Part B• Part B and Part D do not coordinate• Most of our patients will hit coverage gap; plan
for ways to help those in need– Apply for Medicare Savings Programs– Meet spenddown 9/1-12/31 any year– Apply for SPAP, charities, check with drug companies
Kidney Medicare Drugs Awareness and Education Initiative
Transplant Specific Issues
• Although Part D formularies must only have 2 drugs per class, they must have “all or essentially all” immunosuppressants– Covered under Part B if patient meets criteria– Covered under Part D if on formulary and patient
does not meet Part B criteria
• Transplant patients with ESRD only Medicare can have Medicare and Part D 36 months
• Transplant patients with Medicare can keep Medicare and Part D indefinitely if they have Medicare due to age or disability
Kidney Medicare Drugs Awareness and Education Initiative
Warnings!• Patients with COBRA can lose COBRA by signing up for
Medicare to get Part D (general materials have no warnings about this)
• Patients with Medicare Advantage (HMO, PPO) will lose MA health plan by joining a stand-alone Part D plan (applications and materials have warnings)
• Employers may cancel coverage if patient joins a Part D plan. Patients should check with employer before making a decision about Part D. (CMS is developing a process to report employers who cancel employee coverage.)
• Employers may urge those with kidney disease to take Part D and drop health coverage. ADA prohibits this if other employees in similar positions can keep coverage. (Report ADA violations to EEOC.)
Kidney Medicare Drugs Awareness and Education Initiative
THE RIGHT INFORMATION AT THE
RIGHT TIME
Kidney Medicare Drugs Awareness and Education Initiative
PHASE ONE:AWARENESS
July-August 2005
Kidney Medicare Drugs Awareness and Education Initiative
PHASE TWO:EDUCATION
September-October 2005
Kidney Medicare Drugs Awareness and Education Initiative
PHASE THREE: ACTION
November-December 2005
Kidney Medicare Drugs Awareness and Education Initiative
PHASE FOUR: HOW TO MAXIMIZE
PRESCRIPTION DRUG BENEFITS IN A
MEDICARE PART D PLAN
January – March 2006
Kidney Medicare Drugs Awareness and Education Initiative
PHASE FIVE: HOW TO PREPARE FOR
AND COPE WITH THE COVERAGE GAP
April – June 2006
Kidney Medicare Drugs Awareness and Education Initiative
ORGANIZATION RESOURCES
Communications Resource Kit
• A Guide to Understanding Medicare Part D
• Bulletin for staff• Low literacy awareness
message• Web Page/Web Address• Teleconference
announcement
Kidney Medicare Drugs Awareness and Education Initiative
GENERAL PUBLIC RESOURCES
• Web Page/Web Address
• Newsletter articles for different stages
• Low literacy awareness message
Kidney Medicare Drugs Awareness and Education Initiative
MEDICARE—HOW IT’S CHANGING TO HELP MORE PEOPLE
TELECONFERENCE SERIES* Social Workers * Nurses * Dietitians ** Dialysis * Transplant * MD Offices *
August 16, 2005 Overview & Low-income Subsidy
September 20, 2005 Part D Coordination
October 18, 2005 Evaluating & Choosing a Plan
November 15, 2005 Exceptions, Coverage Determinations
December 20, 2005 Appeals & Grievances
January 17, 2006 Filling the Coverage Gap
Kidney Medicare Drugs Awareness and Education Initiative
TOOLS FOR PROFESSIONALS
• Internal data collection tools for MD offices, dialysis clinics, and transplant programs– Medicare Part D Patient Log – Medicare Part D Patient Tracking Form
• Calendar of Key Medicare Part D Dates to help target the right information at the right time
Kidney Medicare Drugs Awareness and Education Initiative
MEDICARE PRESCRIPTION DRUG COVERAGEFOR PEOPLE WITH KIDNEY DISEASE
Patient Characteristics
CKD Stage 1-4
In-Center Dialysis Patients
Home Dialysis Patients• Home hemodialysis• Peritoneal dialysis
Transplant Recipients• <36 months of discharge• 65 or older• After 24 Months of SSDI for
other than kidney failure
Insurance Characteristics
Auto-enrolled• Dual eligible
Facilitated Enrollment• SSI or MSP
Other Low Income Subsidy• <135% FPL or <150% FPL
Medicare Advantage planEmployer/retiree health planState Pharmacy Asst Programs• Prescription plans• State kidney programs
Medigap H, I, JAny Medicare only beneficiary
Kidney Medicare Drugs Awareness and Education Initiative
EDUCATION FOR PEOPLE WITH KIDNEY DISEASE
• 4 Brochures for people with Medicare– Chronic Kidney Disease– In-center Hemodialysis– Home Hemodialysis and
Peritoneal Dialysis– Transplant
Kidney Medicare Drugs Awareness and Education Initiative
EDUCATION FOR PEOPLE WITH KIDNEY DISEASE
• 40 fact sheets for people on Medicare who have kidney disease based on – Stage of kidney disease
and/or treatment type (4)
and– Financial and insurance
status (10)
Kidney Medicare Drugs Awareness and Education Initiative
POSSIBLE FUTURETOOLS AND FACT SHEETS
• Exception request template for doctors to request drugs for patients that are not on the formulary or drugs that are at a higher tier
• Fact sheets for patients, MDs, and kidney care team members on exceptions and appeals and to urge the use of these tactics when needed
• Fact sheet on how to make the most out of True Out-of-Pocket (TrOOP)
• “How-to” for conducting a local kidney-specific Medicare prescription drug coverage workshop
Kidney Medicare Drugs Awareness and Education Initiative
KUDOSKUDOS
Thank you for sending the message (from Patient Thank you for sending the message (from Patient & Family Council listserv). It is the best explanation & Family Council listserv). It is the best explanation of the new Medicare Part D prescription plan that I of the new Medicare Part D prescription plan that I have read and clarifies many points for me.have read and clarifies many points for me.
Jeanie, patientJeanie, patientGreat teleconference. Thanks for providing these Great teleconference. Thanks for providing these wonderful educational opportunities.wonderful educational opportunities.
Laura, MSWLaura, MSWI think NKF could be a prototype for our work with I think NKF could be a prototype for our work with othersothers! !
Janet, CMS
Kidney Medicare Drugs Awareness and Education Initiative
• Tell your patients and staff about this initiative and www.kidneydrugcoverage.org
• Encourage your staff and patients to listen to free 30-minute teleconferences
• Link to www.kidneydrugcoverage.org • Tell us what you’ve developed for our links• Help us find Medicare Prescription Drug
Plans in your region offer “kidney-friendly” formularies
WE NEED YOUR HELP
Kidney Medicare Drugs Awareness and Education Initiative
Participating OrganizationsAbbott Laboratories American Association of Kidney Patients, Inc. American Kidney Fund American Nephrology Nurses’ Association The American Society of Nephrology Amgen Astellas Pharma US, Inc. Centers for Medicare & Medicaid Services Central Florida Kidney Center, Inc. DaVita, Inc. DaVita Patient Citizens The ESRD Network of New York Fresenius Medical Care North America Gambro Healthcare US Genzyme Corporation Kidney Care Partners Nabi BiopharmaceuticalsNational Kidney Foundation, Inc.• Council of Nephrology Nurses and Technicians• Council of Nephrology Social Workers• Council on Renal Nutrition• People Like Us
National Minority Health Month FoundationNational Renal Administrators Association Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmaceutical Research and Manufacturers of
America PKD FoundationRenal Care Group, Inc. The Renal Network, Inc. Renal Physicians Association Renal Support Network Roche Pharmaceuticals Sigma-Tau Pharmaceuticals, Inc. Social Security Administration Transplant News The Transplant Pharmacy Coalition UnitedHealth Group/Ovations Washington Hospital Center Wyeth Pharmaceuticals
Abbott Laboratories American Association of Kidney Patients, Inc. American Kidney Fund American Nephrology Nurses’ Association The American Society of Nephrology Amgen Astellas Pharma US, Inc. Centers for Medicare & Medicaid Services Central Florida Kidney Center, Inc. DaVita, Inc. DaVita Patient Citizens The ESRD Network of New York Fresenius Medical Care North America Gambro Healthcare US Genzyme Corporation Kidney Care Partners Nabi BiopharmaceuticalsNational Kidney Foundation, Inc.• Council of Nephrology Nurses and Technicians• Council of Nephrology Social Workers• Council on Renal Nutrition• People Like Us
National Minority Health Month FoundationNational Renal Administrators Association Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmaceutical Research and Manufacturers of
America PKD FoundationRenal Care Group, Inc. The Renal Network, Inc. Renal Physicians Association Renal Support Network Roche Pharmaceuticals Sigma-Tau Pharmaceuticals, Inc. Social Security Administration Transplant News The Transplant Pharmacy Coalition UnitedHealth Group/Ovations Washington Hospital Center Wyeth Pharmaceuticals